KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$4.71
+7.82%
Mkt Cap $187.02M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
Implied Upside
+287.3%
Consensus $18.25 vs current $4.71
NASDAQ·Healthcare·Biotechnology
$4.71
+7.82%
Mkt Cap $187.02M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
+287.3%
Consensus $18.25 vs current $4.71